Biological Age Test — DNA Methylation Clock Explained

What Biological Age Measures

Biological age is an estimate of how well your body is functioning compared to the average person of your chronological age. Unlike chronological age — which simply counts the number of years you have been alive — biological age reflects the cumulative effects of lifestyle, environment, and genetics on your body's systems. It is a concept rooted in the field of geroscience, which studies the biological mechanisms of aging and how they can be slowed or partially reversed.

A biological age lower than your chronological age suggests that your body is aging more slowly than the population average, indicating better-than-expected health status. A biological age higher than your chronological age suggests that certain health markers or lifestyle factors are accelerating the aging process. The goal is not to obsess over a single number, but to use it as a motivating signal for positive health changes.

How Biological Age Is Estimated

This calculator estimates biological age by starting from your chronological age and applying adjustments based on key health markers and lifestyle factors. Each factor is associated with a year adjustment derived from epidemiological research on aging biomarkers. The net adjustment is the sum of all individual factor adjustments:

Factor Adjustment Table

Worked Example

Consider a 45-year-old male with the following profile: BMI 27 (overweight, +1 year), resting heart rate 72 bpm (+1 year), blood pressure 135 systolic (+1 year), exercises 2 days/week (+1 year), sleeps 6.5 hours/night (+1 year), non-smoker (0), drinks alcohol regularly (+1 year). Total adjustments: +1 + 1 + 1 + 1 + 1 + 0 + 1 = +6 years. Estimated biological age = 45 + 6 = 51 years. This suggests his health and lifestyle patterns are accelerating his biological aging by approximately 6 years relative to the population average.

FAQ-Style Explanations

Can biological age be lower than chronological age? Yes. If you have favorable health markers — a healthy BMI, low resting heart rate, normal blood pressure, regular exercise, adequate sleep, and no smoking or excessive alcohol — your biological age can be lower than your chronological age. This indicates better-than-average health status.

Why does smoking add 5 years? Smoking is one of the most powerful accelerators of biological aging. It damages DNA, increases oxidative stress, impairs circulation, and accelerates cellular senescence. Epidemiological studies consistently show that smokers have significantly shorter telomeres and higher mortality risk across all age groups.

Why does being female give a −1 year adjustment? On average, women live longer than men across most populations worldwide. This sex difference is believed to be partly related to hormonal factors (estrogen's protective effects on cardiovascular health), differences in immune function, and behavioral patterns. The −1 year adjustment reflects this population-level longevity advantage.

Known Limitations

• This is an estimate based on population averages, not a clinical diagnostic tool. Actual biological age assessment can involve more detailed biomarkers such as telomere length, DNA methylation patterns, and advanced blood chemistry panels.
• The adjustment values are derived from epidemiological studies that show associations, not necessarily direct causation for every individual.
• Does not account for family history, genetic predispositions, or specific medical conditions that can independently affect aging.
• The model assumes additive effects of factors, but in reality, interactions between factors (e.g., smoking and exercise) can be complex and non-linear.
• Results may be less accurate for individuals with extreme values, chronic health conditions, or those taking medications that affect the measured markers.

What DNA Methylation Measures

DNA methylation is an epigenetic process in which methyl groups are added to specific locations on DNA, influencing which genes are expressed without changing the underlying genetic sequence. Certain methylation patterns change in highly predictable ways with age, and these age-related methylation patterns can be measured and used to estimate biological age with remarkable precision. Epigenetic clocks are mathematical models that convert methylation measurements at selected CpG sites into an age estimate. The concept was pioneered by Steve Horvath in 2013, who developed the first-generation clock using methylation data from over 8,000 samples across 51 tissue types. Since then, multiple improved clocks have been developed, each optimised for different tissues or predictive goals. The most widely used clocks today — Horvath Clock, GrimAge, and DunedinPACE — are validated across large populations and correlate strongly with all-cause mortality, cardiovascular disease, and functional decline.

Horvath Clock (2013) — The Original Epigenetic Clock

The Horvath Clock, published in Genome Biology in 2013, was the first epigenetic clock capable of accurately estimating age across multiple tissue types from a single model. It uses methylation levels at 353 CpG sites to predict age, with a mean absolute error of 3.6 years in blood samples. The clock was trained on methylation data from over 8,000 samples spanning 51 different tissue types, making it unique in its tissue-agnostic design. It has since been validated in populations exceeding 100,000 individuals and has been shown to correlate with all-cause mortality, with each additional year of Horvath Clock age associated with a 2.1 percent increase in mortality risk. The clock has been widely used in research settings to assess the biological aging effects of interventions such as caloric restriction, exercise, and drug treatments. Its simplicity and broad tissue applicability make it the most widely cited epigenetic clock in the scientific literature, though it is increasingly being supplemented or replaced by clocks that more directly predict mortality risk.

GrimAge (2019) — The Mortality-Predicting Clock

GrimAge, developed by Steve Horvath and colleagues and published in Genome Biology in 2019, is currently the strongest epigenetic predictor of remaining lifespan. Unlike the original Horvath Clock, which was trained to estimate chronological age, GrimAge was trained using DNA methylation patterns associated with smoking-pack-years and surrogate markers of mortality (plasma proteins including PAI-1, ADMA, and TIMP-2), making it a direct predictor of mortality risk rather than just age. It uses 1,030 CpG sites and has a mean absolute error of 2.2 years in blood samples. In validation studies, GrimAge has been shown to predict all-cause mortality 2 to 3 times more strongly than chronological age, and it outperforms all other biological age measures in predicting lifespan in multiple cohorts. GrimAge is now the preferred clock for clinical research and is the basis for most commercial direct-to-consumer biological age tests. A GrimAge acceleration of 5 years or more in someone under 50 is considered clinically significant and is associated with substantially elevated mortality risk.

Commercial Tests — TruAge, Zymo, and Others

Several companies now offer direct-to-consumer biological age tests based on GrimAge or related epigenetic clocks. TruAge, developed by the Zymo Research Corporation, is one of the most established commercial options, using a finger-prick blood sample to measure methylation at 808 CpG sites and report a GrimAge-based biological age estimate. The standard TruAge test costs approximately $295 and typically returns results within 2 to 3 weeks. Other commercial options include EpicWolves, ZymoResearch, and various direct-to-consumer kits from companies such as Notable Labs (which uses a different approach based on proteomics). The general price range for epigenetic biological age tests is $150 to $300, though pricing has been decreasing as the technology matures. Most commercial tests now include a comparison of your biological age to your chronological age, a trend over time if you repeat the test, and sometimes recommendations based on your result. Accuracy of commercial tests is comparable to research settings at plus or minus 2 to 3 years, though individual variation and sample quality can affect precision.

Limitations and Considerations

Despite the remarkable precision of epigenetic clocks, there are important limitations to keep in mind when interpreting biological age test results. First, the clocks were primarily trained on blood samples, and results from blood do not necessarily reflect the aging status of other tissues such as the brain, liver, or muscles — a person may have a young epigenetic age in blood while having an older liver, for example. Second, the tests measure current state rather than future risk in isolation; a young biological age today does not guarantee a long life if lifestyle changes for the worse. Third, the clinical utility of biological age tests is still being established: while the associations with mortality are clear in research, it is not yet known whether acting on biological age test results improves health outcomes better than acting on traditional risk factors. Finally, the tests do not identify specific disease risks — they provide a global aging estimate. For clinical decision-making, epigenetic clocks should be used as a complementary tool alongside traditional biomarkers, medical history, and physician assessment, not as a standalone diagnostic.